Skip to content

Medical emergency? What to do

Roche says it's on track to raise Tamiflu production

3-RXPublished November 8, 20052 min read

Key points

  • Roche will raise the production of its antiviral drug Tamiflu, the drugmaker said, just as the World Health Organisation warned on Monday that a lethal strain of the avian influenza virus was spreading fast.
  • "We have continually increased our production capacities and are now putting in place the means to increase production of Tamiflu to 300 million treatments as of 2007," William Burns, chief executive of Roche's Pharma division, said.
  • The virus has led to the culling of 150 million birds worldwide but it remains hard for people to catch, having killed 63 people in Asia so far.
  • The World Health Organisation, holding a meeting with the World Bank and others to coordinate funding to battle bird flu, said on Monday the lethal H5N1 strand of the virus responsible so far for the death of humans is spreading fast.

Roche will raise the production of its antiviral drug Tamiflu, the drugmaker said, just as the World Health Organisation warned on Monday that a lethal strain of the avian influenza virus was spreading fast.

The Swiss firm said it is in talks with other drugmakers and with governments to step up the production of Tamiflu -- seen as the most effective drug to fight bird flu -- as the world braces for the possibility of a catastrophic pandemic among humans.

"We have continually increased our production capacities and are now putting in place the means to increase production of Tamiflu to 300 million treatments as of 2007," William Burns, chief executive of Roche's Pharma division, said.

Tamiflu, known generically as oseltamivir, is one of a class of antiviral drugs known as neuraminidase inhibitors, which the World Health Organisation has recommended governments should stockpile to prepare for the spreading of the virus.

The virus has led to the culling of 150 million birds worldwide but it remains hard for people to catch, having killed 63 people in Asia so far. Fears are it may change, however, and acquire the ability to be transmitted from human to human.

Governments are scrambling to stock up on Tamiflu, but production is limited. Roche is discussing granting licences to others under pressure from generic drug companies, developing nations and the United States.

SHARING THE BURDEN

The World Health Organisation, holding a meeting with the World Bank and others to coordinate funding to battle bird flu, said on Monday the lethal H5N1 strand of the virus responsible so far for the death of humans is spreading fast.

It is only a matter of time before an avian flu virus acquires the ability to spread between humans, and this could kill between 100,000 and 200,000 people in the United States alone should it unleash a pandemic, it added.

Roche said it received more than 150 requests from third parties to produce Tamiflu and is in early talks with eight companies, selecting potential partners for more detailed discussions by the end of November.

The companies included large generic manufacturers, Roche said, adding it was also in talks with a number of governments, naming Taiwan and Vietnam.

Last month, Roche said it would meet four generic manufacturers to increase production, naming Teva Pharmaceutical Industries Ltd, Barr Pharmaceuticals Inc., Mylan Laboratories Inc. and Ranbaxy Laboratories Ltd.

The extra production meant a tenfold increase over the capacity in 2004 when Roche first decided to step up the speed with which it makes Tamiflu, it said.

The bird-flu virus has recently moved from Asia to eastern Europe and is expected to move into the Middle East and Africa soon.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.